Although key regulators of SOX10 function are under intense investigation and may serve as potential therapeutic strategies to target SOX10 tumorigenic activity in melanoma (14–25), such studies have failed to yield meaningful progress to date. This evidence concerns the gene SOX10 and melanoma.